Beyond the data deluge: Immune profiling in early immuno-oncology trials

Designing immune monitoring programs for early-phase immuno-oncology trials requires not only scientific rigor but also strategic decisions about cost, technology, and operational logistics.

This webinar provides practical guidance on how to select and integrate advanced assay platforms such as high-content flow cytometry and multiplex immunofluorescence (mIF), with a clear focus on cost, data relevance, and operational feasibility.

Experts from Precision for Medicine will share how to extract meaningful data instead of just generating large data sets. They will also cover key considerations for experimental design, sample collection, and platform integration to ensure impactful outcomes for pharmacodynamic and biomarker studies.

Key Takeaways:

• How to Prioritize Cost and Data Value: Evaluate up front which advanced immune monitoring technologies deliver useful data versus overwhelming volume especially with high-content platforms like flow and mIF.
• Choosing & Integrating Platforms: Strategic approaches to selecting and combining complementary and independent assay technologies for robust immune monitoring across sample types.
• Balancing Science, Operations, and Logistics: Practical guidance on experimental design and sample handling that maximizes data relevance while streamlining clinical operations.
• Avoiding Common Pitfalls: Key factors to avoid typical missteps in platform selection, assay planning, and biomarker strategy for impactful and effective early-phase studies.
   

  Register now to gain expert insights into building smarter immune monitoring strategies.